CERTAVUE
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 15 Oct 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79439980
- Mark type
- Stylized text
- Filed
- 15 Oct 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
- Class 010 — Medical apparatus: Medical apparatus for diagnosing or treating respiratory conditions, diabetes, cardiovascular and metabolic disorders, diseases of the nervous system, inflammatory disorders, infectious diseases and for use in dermatology
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jan 2026 — ASSIGNED TO EXAMINER
- 13 Jan 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 13 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 13 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 13 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 13 Jan 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Dec 2025 — APPLICATION FILING RECEIPT MAILED
- 31 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 Dec 2025 — LIMITATION FROM ORIGINAL APPLICATION ENTERED
- 25 Dec 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB